Page last updated: 2024-11-06

thymidine and Viremia

thymidine has been researched along with Viremia in 9 studies

Viremia: The presence of viruses in the blood.

Research Excerpts

ExcerptRelevanceReference
"To observe the success rate of telbivudine (LdT) for the prevention of perinatal transmission of hepatitis B virus (HBV) and the incidence of alanine aminotransferase (ALT) elevation during LdT treatment and after LdT withdrawal in HBV-infected pregnant woman with high viremia in immune-tolerant phase and receiving LdT treatment at the end of pregnancy, and to evaluate the efficacy of LdT in the prevention of perinatal transmission and the safety for pregnant women."7.83[Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal]. ( Bai, H; Ding, Y; Dou, XG; Fan, YX; Han, C; Li, BJ; Li, YW; Sheng, QJ; Zhang, C, 2016)
"To investigate the efficacy and safety of telbivudine for blocking mother-to-child transmission of hepatitis B virus (HBV) in pregnant women with high viremia."7.81[Predictive value of telbivudine in preventing mother-to-infant transmission of hepatitis B virus in pregnant women with high viremia]. ( Hao, A; Li, M; Liu, W; Ma, L; Song, M; Sun, W; Xin, Y, 2015)
"This study indicates that newer antivirals are effective and safe in HTR with CHB."5.43Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients. ( Andini, R; Durante-Mangoni, E; Falco, E; Iossa, D; Maiello, C; Parrella, A; Ragone, E; Utili, R; Vitrone, M; Zampino, R, 2016)
"To observe the success rate of telbivudine (LdT) for the prevention of perinatal transmission of hepatitis B virus (HBV) and the incidence of alanine aminotransferase (ALT) elevation during LdT treatment and after LdT withdrawal in HBV-infected pregnant woman with high viremia in immune-tolerant phase and receiving LdT treatment at the end of pregnancy, and to evaluate the efficacy of LdT in the prevention of perinatal transmission and the safety for pregnant women."3.83[Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal]. ( Bai, H; Ding, Y; Dou, XG; Fan, YX; Han, C; Li, BJ; Li, YW; Sheng, QJ; Zhang, C, 2016)
"To investigate the efficacy and safety of telbivudine for blocking mother-to-child transmission of hepatitis B virus (HBV) in pregnant women with high viremia."3.81[Predictive value of telbivudine in preventing mother-to-infant transmission of hepatitis B virus in pregnant women with high viremia]. ( Hao, A; Li, M; Liu, W; Ma, L; Song, M; Sun, W; Xin, Y, 2015)
" We studied longitudinally 18 hepatitis B e antigen (HBeAg)-positive patients undergoing treatment with direct antivirals (telbivudine or lamivudine) to determine the relationship between treatment-induced viremia reduction and HBeAg seroconversion with respect to PD-1 levels and T-cell reactivity."3.74Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion. ( Brett, S; Chokshi, S; Cooksley, H; Evans, A; Naoumov, NV; Nathwani, A; Phillips, S; Puranik, S; Riva, A, 2008)
"This study indicates that newer antivirals are effective and safe in HTR with CHB."1.43Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients. ( Andini, R; Durante-Mangoni, E; Falco, E; Iossa, D; Maiello, C; Parrella, A; Ragone, E; Utili, R; Vitrone, M; Zampino, R, 2016)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerlich, WH1
Dunkelberg, JC1
Berkley, EM1
Thiel, KW1
Leslie, KK1
Sun, W1
Ma, L1
Hao, A1
Liu, W1
Song, M1
Li, M1
Xin, Y1
Durante-Mangoni, E1
Vitrone, M1
Parrella, A1
Andini, R1
Iossa, D1
Ragone, E1
Falco, E1
Maiello, C1
Utili, R1
Zampino, R1
Sheng, QJ1
Ding, Y1
Li, BJ1
Bai, H1
Zhang, C1
Han, C1
Fan, YX1
Li, YW1
Dou, XG1
Evans, A1
Riva, A1
Cooksley, H1
Phillips, S1
Puranik, S1
Nathwani, A1
Brett, S1
Chokshi, S1
Naoumov, NV1
Coppola, N1
Masiello, A1
Tonziello, G1
Macera, M1
Iodice, V1
Caprio, N1
Pasquale, G1
Bruland, T1
Lavik, LA1
Dai, HY1
Dalen, A1
Ross, L1
Scarsella, A1
Raffanti, S1
Henry, K1
Becker, S1
Fisher, R1
Liao, Q1
Hirani, A1
Graham, N1
St Clair, M1
Hernandez, J1

Reviews

1 review available for thymidine and Viremia

ArticleYear
Hepatitis B and C in pregnancy: a review and recommendations for care.
    Journal of perinatology : official journal of the California Perinatal Association, 2014, Volume: 34, Issue:12

    Topics: Antiviral Agents; Breast Feeding; Cesarean Section; Contraindications; DNA, Viral; Female; Hepatitis

2014

Other Studies

8 other studies available for thymidine and Viremia

ArticleYear
Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy.
    Intervirology, 2014, Volume: 57, Issue:3-4

    Topics: Adenine; Antiviral Agents; DNA, Viral; Female; Guanine; Health Personnel; Hepatitis B e Antigens; He

2014
[Predictive value of telbivudine in preventing mother-to-infant transmission of hepatitis B virus in pregnant women with high viremia].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2015, Volume: 23, Issue:3

    Topics: Female; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobuli

2015
Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Cohort Studies; DNA, Viral; Female; Follow-Up Studies; Guanine; Heart

2016
[Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2016, Volume: 24, Issue:4

    Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; In

2016
Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:3

    Topics: Adult; Alanine Transaminase; Antigens, CD; Antiviral Agents; Apoptosis Regulatory Proteins; Biopsy;

2008
[Icteric hepatitis in a patient with non-Hodgkin's lymphoma treated by rituximab-based chemotherapy].
    Le infezioni in medicina, 2010, Volume: 18, Issue:2

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Ag

2010
Identification of Friend murine retrovirus-infected immune cells and studies of the effects of sex and steroid hormones in the early phase of infection.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2003, Volume: 111, Issue:9

    Topics: 3T3 Cells; Animals; CD8-Positive T-Lymphocytes; Cell Division; Dexamethasone; Female; Flow Cytometry

2003
Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.
    AIDS research and human retroviruses, 2001, Aug-10, Volume: 17, Issue:12

    Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; H

2001